Drug Profile

Ketoconazole topical - Vyome Therapeutics

Alternative Names: Ketoconazole MRT™; VB 7731

Latest Information Update: 25 Aug 2023

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Vyome Biosciences
Developer Vyome Therapeutics
Class Antifungals; Azoles; Piperazines; Small molecules
Mechanism of Action 14-alpha demethylase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No
Available For Licensing Yes - Mycoses

Highest Development Phases

Discontinued Mycoses

Most Recent Events

25 Aug 2023 Discontinued - Preclinical for Mycoses in India (Topical)
28 Feb 2020 No recent reports of development identified for preclinical development in Mycoses in India (Topical, Gel)
12 Jan 2016 VB 7731 is available for licensing as of 12 Jan 2016. http://www.vyome.in/

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com